全文获取类型
收费全文 | 3145篇 |
免费 | 269篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 117篇 |
妇产科学 | 49篇 |
基础医学 | 383篇 |
口腔科学 | 104篇 |
临床医学 | 304篇 |
内科学 | 622篇 |
皮肤病学 | 30篇 |
神经病学 | 320篇 |
特种医学 | 214篇 |
外科学 | 386篇 |
综合类 | 74篇 |
一般理论 | 3篇 |
预防医学 | 331篇 |
眼科学 | 22篇 |
药学 | 299篇 |
中国医学 | 9篇 |
肿瘤学 | 147篇 |
出版年
2022年 | 24篇 |
2021年 | 35篇 |
2020年 | 18篇 |
2019年 | 56篇 |
2018年 | 69篇 |
2017年 | 35篇 |
2016年 | 69篇 |
2015年 | 115篇 |
2014年 | 104篇 |
2013年 | 97篇 |
2012年 | 150篇 |
2011年 | 147篇 |
2010年 | 109篇 |
2009年 | 74篇 |
2008年 | 146篇 |
2007年 | 117篇 |
2006年 | 101篇 |
2005年 | 130篇 |
2004年 | 122篇 |
2003年 | 115篇 |
2002年 | 120篇 |
2001年 | 99篇 |
2000年 | 88篇 |
1999年 | 77篇 |
1998年 | 53篇 |
1997年 | 65篇 |
1996年 | 59篇 |
1995年 | 51篇 |
1994年 | 43篇 |
1993年 | 39篇 |
1992年 | 66篇 |
1991年 | 68篇 |
1990年 | 49篇 |
1989年 | 58篇 |
1988年 | 56篇 |
1987年 | 39篇 |
1986年 | 34篇 |
1985年 | 42篇 |
1984年 | 34篇 |
1983年 | 34篇 |
1982年 | 28篇 |
1981年 | 22篇 |
1980年 | 27篇 |
1979年 | 31篇 |
1978年 | 38篇 |
1977年 | 20篇 |
1976年 | 24篇 |
1973年 | 23篇 |
1972年 | 18篇 |
1969年 | 21篇 |
排序方式: 共有3426条查询结果,搜索用时 0 毫秒
71.
Olanrewaju Edun Yulia Shenderovich Siyanai Zhou Elona Toska Lucy Okell Jeffrey W. Eaton Lucie Cluver 《Journal of the International AIDS Society》2022,25(5)
IntroductionThe World Health Organization recommends full disclosure of HIV‐positive status to adolescents who acquired HIV perinatally (APHIV) by age 12. However, even among adolescents (aged 10–19) already on antiretroviral therapy (ART), disclosure rates are low. Caregivers often report the child being too young and fear of disclosure worsening adolescents’ mental health as reasons for non‐disclosure. We aimed to identify the predictors of disclosure and the association of disclosure with adherence, viral suppression and mental health outcomes among adolescents in sub‐Saharan Africa.MethodsAnalyses included three rounds (2014–2018) of data collected among a closed cohort of adolescents living with HIV in Eastern Cape, South Africa. We used logistic regression with respondent random‐effects to identify factors associated with disclosure, and assess differences in ART adherence, viral suppression and mental health symptoms between adolescents by disclosure status. We also explored differences in the change in mental health symptoms and adherence between study rounds and disclosure groups with logistic regression.ResultsEight hundred and thirteen APHIV were interviewed at baseline, of whom 769 (94.6%) and 729 (89.7%) were interviewed at the second and third rounds, respectively. The proportion aware of their HIV‐positive status increased from 63.1% at the first round to 85.5% by the third round. Older age (adjusted odds ratio [aOR]: 1.27; 1.08–1.48) and living in an urban location (aOR: 2.85; 1.72–4.73) were associated with disclosure between interviews. There was no association between awareness of HIV‐positive status and ART adherence, viral suppression or mental health symptoms among all APHIV interviewed. However, among APHIV not aware of their status at baseline, adherence decreased at the second round among those who were disclosed to (N = 131) and increased among those not disclosed to (N = 151) (interaction aOR: 0.39; 0.19–0.80). There was no significant difference in the change in mental health symptoms between study rounds and disclosure groups.ConclusionsAwareness of HIV‐positive status was not associated with higher rates of mental health symptoms, or lower rates of viral suppression among adolescents. Disclosure was not associated with worse mental health. These findings support the recommendation for timely disclosure to APHIV; however, adherence support post‐disclosure is important. 相似文献
72.
目的:性治疗法目前尚未普及,本研究旨在评价性治疗法联合西地那非治疗勃起功能障碍(ED)的疗效。方法:根据治疗方法的不同将在本院治疗随访过的3130例维吾尔族ED患者分成2组。对照组625例,单纯口服西地那非3个月;试验组2505例,采用性治疗法联合西地那非治疗3个月。采用国际勃起功能问卷表(IIEF-5)在各组治疗前、后进行疗效评估,并随访12个月。结果:对照组治疗前、后及在6个月、12个月随访的IIEF-5评分分别为12.80±3.76、18.10±2.61、17.35±2.73和16.64±2.63;试验组治疗前、后及在6个月、12个月随访的IIEF-5评分分别为12.73±3.52、19.06±4.07、19.86±2.42和20.47±2.38。两组治疗前后IIEF-5评分自身对比差异均有显著性(P<0.05)。组间比较,试验组较对照组6个月和12个月随访IIEF-5评分均有显著性差异(P<0.05)。结论:性治疗法联合西地那非治疗ED的效果优于单纯西地那非治疗,并在12个月的随访中稳定性良好。 相似文献
73.
74.
Emma Jane Poulton Lisa Levy Johanna W. Lampe Danny D. Shen Julia Tracy Margaret C. Shuhart Kenneth E. Thummel David L. Eaton 《Toxicology and applied pharmacology》2013,266(1):122-131
Sulforaphane (SFN), is an effective in vitro antagonist of ligand activation of the human pregnane and xenobiotic receptor (PXR). PXR mediated CYP3A4 up-regulation is implicated in adverse drug-drug interactions making identification of small molecule antagonists a desirable therapeutic goal. SFN is not an antagonist to mouse or rat PXR in vitro; thus, normal rodent species are not suitable as in vivo models for human response. To evaluate whether SFN can effectively antagonize ligand activation of human PXR in vivo, a three-armed, randomized, crossover trial was conducted with 24 healthy adults. The potent PXR ligand — rifampicin (300 mg/d) was given alone for 7 days in arm 1, or in daily combination with 450 μmol SFN (Broccoli Sprout extract) in arm 2; SFN was given alone in arm 3. Midazolam as an in vivo phenotype marker of CYP3A was administered before and after each treatment arm. Rifampicin alone decreased midazolam AUC by 70%, indicative of the expected increase in CYP3A4 activity. Co-treatment with SFN did not reduce CYP3A4 induction. Treatment with SFN alone also did not affect CYP3A4 activity in the cohort as a whole, although in the subset with the highest basal CYP3A4 activity there was a statistically significant increase in midazolam AUC (i.e., decrease in CYP3A4 activity). A parallel study in humanized PXR mice yielded similar results. The parallel effects of SFN between humanized PXR mice and human subjects demonstrate the predictive value of humanized mouse models in situations where species differences in ligand-receptor interactions preclude the use of a native mouse model for studying human ligand-receptor pharmacology. 相似文献
75.
Factor V and factor VIII are homologous cofactors in the blood coagulation cascade that have the domain structure A1-A2-B-A3-C1-C2, of which the B domain has extensively diverged. In transfected COS-1 monkey cells, expression of factor VIII is approximately 10-fold less efficient than that of factor V, primarily because of inefficient protein secretion and, to a lesser extent, reduced mRNA expression. To study the functional significance and effect of the B domain on expression and activity, chimeric cDNAs were constructed in which the B domains of factor V and factor VIII were exchanged. Expression of a factor VIII chimera harboring the B-domain of factor V yielded a fully functional factor VIII molecule that was expressed twofold more efficiently than wild-type factor VIII because of increased mRNA expression. Thus, sequences within the factor VIII B domain were not responsible for the inefficient secretion of factor VIII compared with factor V. Expression of a factor V chimera harboring the B domain of factor VIII was slightly reduced compared with wild-type factor V, although the secreted molecule had significantly reduced procoagulant activity correlating with dissociated heavy and light chains and resistance to thrombin activation. Interestingly, the factor V chimera containing the factor VIII B domain was efficiently activated by Russell's viper venum (RVV). A factor V B domain deletion (residues 710- 1545) molecule also exhibited significantly reduced procoagulant activity caused by resistance to thrombin cleavage and activation, although this molecule was activatable by RVV. These results show that, in contrast to factor VIII, thrombin activation of factor V requires sequences within the B domain. In addition, thrombin activation of factor V occurs through a different mechanism than activation by RVV. 相似文献
76.
Identification of the molecular defect in the erythrocyte membrane skeleton of some kindreds with hereditary spherocytosis 总被引:12,自引:0,他引:12
We have localized the molecular alteration in the membrane skeleton of two of four kindreds with hereditary spherocytosis (HS) to an alteration in the spectrin-protein-4.1 interaction due to a defective spectrin molecule. The defective spectrin-protein-4.1 interaction in these kindreds (referred to as type I HS) leads to a weakened spectrin- protein-4.1-actin ternary complex, which in turn may lead to the friable membrane skeleton and suggested membrane instability related to this disorder. Type I HS spectrin binds approximately 63% as much protein-4.1 as normal spectrin (with equal affinity). This defect does not correlate with splenic function or erythrocyte age in the circulation. However, the approximately 37% reduction in binding of protein-4.1 to HS spectrin approaches the theoretical value of 50% expected in this autosomal dominant disorder. All other type I membrane skeletal interactions (spectrin-syndein, spectrin heterodimer- heterodimer, syndein-band-3) were found to be normal. It would appear therefore that the defective HS spectrin-protein-4.1 interaction in type I hereditary spherocytosis may be the primary molecular defect rather than a secondary phenomena. 相似文献
77.
再发骨质疏松性椎体压缩骨折保守治疗患者出院后生存质量 总被引:1,自引:0,他引:1
目的:对比初次和再发骨质疏松性椎体压缩骨折(osteoporotic vertebral compression fractures,OVCFs)患者保
守治疗的生存质量,了解再次骨折对此类患者生存质量各方面的影响。方法:回顾性观察治疗OVCFs后出现再骨折
的患者30名(再骨折组)和同时期行保守治疗OVCFs后未发生再骨折的基本条件相似的患者30例(对照组),比较两组出
院后3个月时SF-36简明健康健康状况调查表的调查结果。结果:再骨折组治疗后的8个维度均不同程度较对照组变差
(均P<0.01)。结论:再骨折组患者的生存质量明显低于对照组,并且会进一步影响患者的心理预期、情绪和社会活动
的各个方面。 相似文献
78.
79.
Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function 总被引:12,自引:0,他引:12
Craig B. Thompson Katherine A. Eaton Steven M. Princiotta Carol A. Rushin C. Robert Valeri 《British journal of haematology》1982,50(3):509-519
A method for the separation of platelets on the basis of their size has been developed using counterflow centrifugation. Platelets were separated, free of plasma proteins and other cells, into seven subpopulations. The smallest-sized platelets, designated as Fraction 1, had a mean platelet volume (MPV) of 3.94 ± 0.60 μm3 (SD). Each successive fraction had a progressively larger MPV. The MPV for the largest-sized platelets, designated Fraction 7, was 8.19 ± 0.64 μm3 . The MPV for the original platelets prior to fractionation was 6.57 ± 0.61 μm3 . The mean density of Fraction 1 platelets was 1.067 ± 0.002 g/cm3 , while Fraction 7 had a mean density of 1.072 ± 0.001 g/cm3 . Transmission electron microscopy demonstrated that Fraction 1 had 4.3 ± 0.9 dense bodies per platelet, and Fraction 7 had 12.6 ± 2.4 dense bodies per platelet. Platelet LDH activity showed that the Fraction 1 platelets had 4.77 ± 0.92 iu per 1010 platelets; Fraction 7 platelets had 14.88 ± 1.23 iu per 1010 platelets. The LDH activity in the platelets before separation into subpopulations was 9.47 ± 1.45 iu per 1010 platelets. 相似文献
80.